TIA in successful MTPConnect project grant 

The Australia-China Life Sciences Partnership Program receives funding from MTPConnect’s Project Fund Program

Thursday, 26 October 2017 - Melbourne, Australia:

MTPConnect - the Medical Technologies and Pharmaceuticals Industry Growth Centre - today announced it will provide a proposed $170,000 provisional funding to The Australia-China Life Sciences Partnership Program over two years, with proposed matched funding of $170,000 coming from the sector. The funding will allow the project partners, which include AusBiotech, Therapeutic Innovation Australia, Asia-Link Business, KPMG, China Blue Sky partners, FB Rice and King & Wood Mallesons (KWM) to develop a strong platform to enable Australian SMEs and researchers to engage with the rapidly growing Chinese market.

The funding will allow the ‘Australia-China Life Sciences Partnership Program’ to increase awareness and opportunities for communication, collaboration and commercialisation between the life sciences sector in Australia and China, to deliver high-quality, collaborative research and industry projects as well as valuable data analytics on commercial engagement between the two countries.

TIA will contribute data from its ATRAX resource. ATRAX is a database of funded Australian medical research projects - this data will provide information on selected funded projects with potential to be promoted to Chinese investors.

 

For more information on this exciting new project, visit the AusBiotech website.

Level 14, 330 Collins St

Melbourne 3000 VIC

Call

T: +61 (07) 3735 4433

©2019 Therapeutic Innovation Australia

Enabled by

NCRIS-PROVIDER-RGB-REV.png